Chugai Pharmaceutical Co., Ltd.
CHGCF
$42.03
-$1.06-2.45%
OTC PK
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -713.14M | 833.22M | -673.22M | 638.03M | -- |
| Total Depreciation and Amortization | -3.09M | 203.97M | -2.77M | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.87B | -996.17M | -245.97M | -467.94M | -276.26M |
| Change in Net Operating Assets | -370.91M | 796.72M | 1.75B | 267.43M | 956.07M |
| Cash from Operations | 785.09M | 837.74M | 826.74M | 437.52M | 679.81M |
| Capital Expenditure | -52.71M | -112.72M | -185.72M | -145.02M | -83.38M |
| Sale of Property, Plant, and Equipment | -370.70K | 1.45M | 50.94M | -- | -640.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -872.78M | -938.12M | -187.74M | -425.11M | -133.20M |
| Cash from Investing | -925.86M | -1.05B | -322.53M | -570.13M | -217.22M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 2.51B | 5.93B | 2.03B | -2.03B | -- |
| Issuance of Common Stock | 0.00 | 12.00M | 11.00M | 115.00M | 75.00M |
| Repurchase of Common Stock | -3.93B | -3.00M | -1.00M | -1.00M | -3.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -3.03M | -612.93M | -437.61M |
| Other Financing Activities | -4.94B | -8.32B | -4.07B | -51.00M | -1.98B |
| Cash from Financing | -38.86M | -14.63M | -17.07M | -625.85M | -450.49M |
| Foreign Exchange rate Adjustments | 9.44M | 32.71M | 22.92M | -7.85M | 16.11M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 6.70K |
| Net Change in Cash | -170.19M | -193.56M | 510.06M | -766.31M | 28.22M |